News

Multimedia

Conferences

Publications

Resources

Technology

Latest News

Gaugarin Oliver

AI in Pharma: Where, When, and How Executives are Considering it

By Gaugarin Oliver

November 19th 2024

As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

Drilling in on Disease Hallmarks: New Tricks to Solve Age-Old Problems

November 15th 2024

The Leap Forward: Practical Gains for Pharma AI Use

The Leap Forward: Practical Gains for Pharma AI Use

By Bianca Anghelina
Helen Merianos

November 14th 2024

Abby Reynolds

The Rise of Digital Platforms: Q&A with Abby Reynolds

November 14th 2024

Passage to Asia: Early Access for Innovative Therapies

Passage to Asia: Early Access for Innovative Therapies

November 13th 2024

More News

Adverse Event Reporting by HCPs Problematic

September 16th 2015

September 17, 2015.

Global Ischemic Heart Disease Market to Grow at 3.61% CAGR to 2019

September 16th 2015

September 17, 2015.

CMO Industry Growth Unsustainable, Says Report

Pharmaceutical Technology

September 15th 2015

September 15, 2015.

Raptor Drug Study Failure Wipes a Third Off Company Value

September 15th 2015

September 15, 2015.

Depomed Board Urges Rejection of Horizon Pharma Offer

September 14th 2015

September 14, 2015.

Pneumonia Vaccine Market to Reach $11bn by 2020

September 14th 2015

September 14, 2015.

Mylan Commences Formal Offer to Acquire Perrigo

September 14th 2015

September 14, 2015.

India Reports Surge in Pharma Market

September 11th 2015

September 11, 2015.

Biosimilars Forum Still Pushing for Unique J-Codes

Randi Hernandez

September 10th 2015

September 10, 2015.

BIO and BIA Call for Review of US Court Decision on Fetal DNA Test Patent

September 10th 2015

September 10, 2015.

Integral 3D Barcode Could Fight Pharma Fakes

September 10th 2015

September 10, 2015.

Syncing Personalized Medicine and Marketing

Syncing Personalized Medicine and Marketing

September 9th 2015

The age of genomics is giving rise to highly specialized diagnostic tools, targeted therapies, and personalized drug monitoring. This new generation of individualized treatments will require life sciences companies to evolve how they reach and educate the healthcare community. Are your commercial operations up to the task?

FDA Releases Guidance on Formal Disputes

Pharmaceutical Technology

September 9th 2015

September 09, 2015.

EMA Establishes Orphan Drugs Workshop

Pharmaceutical Technology

September 9th 2015

September 09, 2015.

Celsion Announces 15–20 Percent Workforce Cut

September 9th 2015

September 09, 2015.

Shire's Bid for Baxalta: Beware the "Synergies"

September 8th 2015

September 08, 2015.

2014 Record Year for Antisense RNAi Therapeutics Deals

September 3rd 2015

September 03, 2015.

UCB to Sell Generics Subsidiary to Lannett

September 3rd 2015

September 03, 2015.

European Industry Takes French Regulators To Task Over Temporary Authorization

September 2nd 2015

September 02, 2015.

Branded ACS Therapies to Grab Market Share from Generics, Says Report

September 2nd 2015

September 2, 2015.

NHS England Survey: Staff Struggling With Severe Financial Pressure

September 2nd 2015

September 02, 2015.

More Than Half US Physicians Place Moderate-to-Severe Restrictions on Pharma Sales Reps

September 2nd 2015

September 02, 2015.

What Time is It? Time to Get a Wearable Strategy

What Time is It? Time to Get a Wearable Strategy

September 1st 2015

The success of Apple's iWatch is part of the apparently unstoppable rise of wearable technology, in particular health and fitness applications, writes Peter Houston.

New Actos Trial Begins in Las Vegas

August 28th 2015

August 28, 2015.

FDA Releases Guidance on Biosimilar Naming

Randi Hernandez

August 28th 2015

August 28, 2015.

GSK to Divest Ofatumumab to Novartis Pharma

August 28th 2015

GSK announces plan to divest its rights in ofatumumab for auto-immune indications for up to $1 billion.

Perrigo Confident Shareholders "Will Reject Mylan's Value Destructive Transaction"

August 28th 2015

August 28, 2015.

Novo Nordisk to Start Phase III Trial for Oral Biologic

Randi Hernandez

August 27th 2015

August 27, 2015.

Pfizer to Divest Four Injectable Products in Hospira Acquisition

August 27th 2015

August 27, 2015.

US Rep. Introduces Product Information Modernization Bill

August 26th 2015

August 26, 2015.

...

32 33 34 35 36 37 38 39 40

...

Contact Editorial

Editorial Submission Guidelines

Contact MJH Life Sciences

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2024 MJH Life Sciences

All rights reserved.